MAURA SLAVEN: Open Payments
NPI 1932687449 · DENHAM SPRINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 60 payments from 15 companies in 2025. Trend: 2023 $939 · 2024 $782 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $288 |
| Axsome Therapeutics, Inc. | 10 | $255 |
| AstraZeneca Pharmaceuticals LP | 3 | $167 |
| PFIZER INC. | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Novo Nordisk Inc | 4 | $66 |
| Lilly USA, LLC | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $64 |
| Lundbeck LLC | 3 | $51 |
Products named: Auvelity, VRAYLAR, AIRSUPRA, REXULTI, MOUNJARO, CAPLYTA, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
